Adjudication confirmed pancreatitis in 24 patients ( 26 events ) in the saxagliptin arm ( 0.29 % ) and 21 patients ( 25 events ) in placebo arm ( 0.26 % ) , with an HR of 1.13 ( 0.63-2 .06 , P = 0.77 ) .